An extended follow-up study conducted at the University of Jyväskylä shows that low cardiorespiratory fitness in adolescence is associated with higher risk for cardiovascular and metabolic diseases in middle age.
Texas Heart Institute receives $1.14 million grant to develop first-in-class drug to treat cardiovascular disease
The National Heart, Lung, and Blood Institute (NHLBI) recently awarded The Texas Heart Institute (THI) a two-year, $1.14 million grant to develop a novel, first-in-class